HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
- PMID: 20308568
- PMCID: PMC2851961
- DOI: 10.1073/pnas.0915054107
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
Abstract
A proportion of classical Hodgkin lymphoma (HL) is believed to be causally related to infection with the ubiquitous lymphotropic EBV. The determining factors for development of EBV-related HL remain poorly understood, but likely involve immunological control of the viral infection. Accordingly, markers of the HLA class I region have been associated with risk of EBV-related HL. To study the host genetic component of EBV-related HL further, we investigated the lymphoma's association with HLA-A*01 and HLA-A*02 simultaneously in the setting of infectious mononucleosis (IM), a risk factor for EBV-related HL, in a case-series analysis including 278 EBV-related and 656 EBV-unrelated cases of HL. By logistic regression, HLA-A*01 alleles [odds ratio (OR) per allele, 2.15; 95% CI, 1.60-2.88] were associated with increased and HLA-A*02 alleles (OR per allele, 0.70; 95% CI, 0.51-0.97) with decreased risk of EBV-related HL. These allele-specific associations corresponded to nearly 10-fold variation in risk of EBV-related HL between HLA-A*01 and HLA-A*02 homozygotes. History of IM was also associated with risk of EBV-related HL (OR, 3.40; 95% CI, 1.74-6.66). The association between history of IM and EBV-related HL was not seen in the presence of HLA-A*02 because this allele appeared to neutralize the effect of IM on EBV-related HL risk. Our findings suggest that HLA class I-restricted EBV-specific cytotoxic T-cell responses and events in the early immune response to EBV infection in IM play critical roles in the pathogenesis of EBV-related HL.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.Brain. 2024 Oct 3;147(10):3573-3582. doi: 10.1093/brain/awae110. Brain. 2024. PMID: 38630618 Free PMC article.
-
HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.J Clin Invest. 2007 Oct;117(10):3042-8. doi: 10.1172/JCI32377. J Clin Invest. 2007. PMID: 17909631 Free PMC article.
-
Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.Int J Cancer. 2012 Jun 15;130(12):2886-91. doi: 10.1002/ijc.26334. Epub 2011 Aug 30. Int J Cancer. 2012. PMID: 21805472 Free PMC article.
-
On the aetiology of Hodgkin lymphoma.Dan Med J. 2012 Jul;59(7):B4485. Dan Med J. 2012. PMID: 22759852 Review.
-
Human leukocyte antigens and genetic susceptibility to lymphoma.Tissue Antigens. 2015 Aug;86(2):98-113. doi: 10.1111/tan.12604. Tissue Antigens. 2015. PMID: 26189878 Review.
Cited by
-
Evidence of genetic susceptibility to infectious mononucleosis: a twin study.Epidemiol Infect. 2012 Nov;140(11):2089-95. doi: 10.1017/S0950268811002457. Epub 2011 Dec 8. Epidemiol Infect. 2012. PMID: 22152594 Free PMC article.
-
Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.Int J Epidemiol. 2016 Jun;45(3):728-40. doi: 10.1093/ije/dyv364. Epub 2016 Mar 12. Int J Epidemiol. 2016. PMID: 26971321 Free PMC article.
-
HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.PLoS One. 2015 Aug 11;10(8):e0135512. doi: 10.1371/journal.pone.0135512. eCollection 2015. PLoS One. 2015. PMID: 26261988 Free PMC article.
-
The impact of HLA polymorphism on herpesvirus infection and disease.Immunogenetics. 2023 Jun;75(3):231-247. doi: 10.1007/s00251-022-01288-z. Epub 2023 Jan 3. Immunogenetics. 2023. PMID: 36595060 Free PMC article. Review.
-
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.Genome Med. 2019 Apr 30;11(1):26. doi: 10.1186/s13073-019-0640-z. Genome Med. 2019. PMID: 31039804 Free PMC article.
References
-
- Mueller N, Grufferman S. Hodgkin lymphoma. In: Schottenfeld D, Fraumeni J Jr, editors. Cancer Epidemiology and Prevention. Oxford: Oxford Univ Press; 2006. pp. 872–897.
-
- Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2511–2573.
-
- Wu TC, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer. 1990;46:801–804. - PubMed
-
- Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337:320–322. - PubMed
-
- Grässer FA, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood. 1994;84:3792–3798. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials